Results for tag: "Tubulin"

Tubulin is a protein found in all eukaryotic cells and is essential for cell division and movement. It is a major target for drug discovery, as it is involved in many cellular processes and is a key component of the cytoskeleton. Tubulin inhibitors are used to treat a variety of diseases, including cancer, Alzheimer's, and Parkinson's. Tubulin inhibitors can also be used to treat parasitic infections, such as malaria. The tubulin market is a rapidly growing sector of the drug discovery industry. It is driven by the increasing demand for new and effective treatments for a variety of diseases. Companies in the tubulin market are focused on developing novel inhibitors that can target tubulin and its associated pathways. These companies are also exploring new ways to deliver tubulin inhibitors to the target cells. Some of the major companies in the tubulin market include AstraZeneca, Merck, Pfizer, Novartis, and GlaxoSmithKline. These companies are actively researching and developing new tubulin inhibitors for a variety of diseases. Additionally, there are a number of smaller companies and start-ups that are also involved in the tubulin market. Show Less Read more